A team of nephrologists and endocrinologists should jointly determine strategies for the treatment of patients with CKD and thyroid hormone abnormalities, taking into account the individualization of therapy in relation to the needs and clinical condition of the individual patients. This evidence concerns the gene TG and chronic kidney disease.